|
ARHGAP32 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.178400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.018500E-03 |
| Normal-vs-Stage2 |
9.5913000000003E-05 |
| Normal-vs-Stage3 |
3.594500E-02 |
| Normal-vs-Stage4 |
6.646200E-02 |
| Stage1-vs-Stage2 |
4.788300E-02 |
| Stage1-vs-Stage3 |
6.238200E-01 |
| Stage1-vs-Stage4 |
6.932600E-01 |
| Stage2-vs-Stage3 |
4.524000E-02 |
| Stage2-vs-Stage4 |
8.154400E-02 |
| Stage3-vs-Stage4 |
9.922800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.256170E-02 |
| Normal-vs-AfricanAmerican |
2.951200E-01 |
| Normal-vs-Asian |
1.069230E-01 |
| Caucasian-vs-AfricanAmerican |
6.535400E-01 |
| Caucasian-vs-Asian |
9.990600E-01 |
| AfricanAmerican-vs-Asian |
7.229600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.399560E-02 |
| Normal-vs-Female |
6.795000E-03 |
| Male-vs-Female |
9.172000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.179800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.029980E-02 |
| Normal-vs-Age(61-80Yrs) |
7.580100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.237800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.574000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.386000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.329000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.119600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.773000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.618600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.231400E-01 |
| Classical-VS-Follicular |
3.58669760558428E-11 |
| Classical-VS-Other |
4.219600E-01 |
| Classical-VS-Normal |
1.259210E-01 |
| Tall-VS-Follicular |
7.7647999996433E-07 |
| Tall-VS-Other |
2.024400E-01 |
| Tall-VS-Normal |
6.906400E-01 |
| Follicular-VS-Other |
1.722770E-01 |
| Follicular-VS-Normal |
3.9729997070026E-10 |
| Other-VS-Normal |
1.057030E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.213940E-04 |
| Normal-vs-N1 |
4.683600E-01 |
| N0-vs-N1 |
2.712400E-02 |
|
|
